Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PMS2P9 (PMS1 homolog 2, mismatch repair system component pseudogene 9) is classified as a pseudogene, specifically a non-functional homolog of DNA mismatch repair genes located on human chromosome 7[3]. It shares sequence similarity with functional PMS2 family genes but does not code for a functional protein. While the active PMS2 gene plays a role in DNA repair, pseudogenes like PMS2P9 result from duplication or retrotransposition events and are generally not expressed as proteins and have no established biological or disease-related role[3]. This gene is not considered a therapeutic target, nor is it implicated in drug interaction, biomarker use, or safety concerns. PMS2P9 is sometimes referred to by alternative names including PMS2L17, PMS2LP1, and PMSR5[3]. The existence of PMS2 family pseudogenes can complicate genetic analysis, especially when distinguishing pathogenic variants in the actual PMS2 gene, but PMS2P9 itself does not encode an active biological molecule[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PMS1 homolog 2, mismatch repair system component pseudogene 9 (PMS2P9).